title: Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes.
abstract: Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique receptor complex with limited cellular expression outside the liver which may result in a differentiated tolerability profile compared to peginterferon alfa (alfa). In Phase 2b clinical studies, Lambda administered in combination with ribavirin (RBV) was efficacious in patients with hepatitis C virus (HCV) infection representing genotypes 1 through 4, and was associated with more rapid declines in HCV RNA compared to alfa plus RBV. To gain insights into potential mechanisms for this finding, we investigated the effects of HCV replication on IFN signaling in primary human hepatocytes (PHH) and in induced hepatocyte-like cells (iHLCs). HCV infection resulted in rapid down-regulation of the type I IFN-α receptor subunit 1 (IFNAR1) transcript in hepatocytes while the transcriptional level of the unique IFN-λ receptor subunit IL28RA was transiently increased. In line with this observation, IFN signaling was selectively impaired in infected cells upon stimulation with alfa but not in response to Lambda. Importantly, in contrast to alfa, Lambda was able to induce IFN-stimulated gene (ISG) expression in HCV-infected hepatocytes, reflecting the onset of innate responses. Moreover, global transcriptome analysis in hepatocytes indicated that Lambda stimulation prolonged the expression of various ISGs that are potentially beneficial to antiviral defense mechanisms. Collectively, these observed effects of HCV infection on IFN receptor expression and signaling within infected hepatocytes provide a possible explanation for the more pronounced early virologic responses observed in patients treated with Lambda compared to alfa.
authors.affiliation: Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut, United States of America, 06492.
authors.forename: Jacques
authors.initials: J
authors.lastname: Friborg
authors.affiliation: Applied Genomics, Bristol-Myers Squibb Research and Development, Hopewell, NJ, United States of America.
authors.forename: Petra
authors.initials: P
authors.lastname: Ross-Macdonald
authors.affiliation: Applied Genomics, Bristol-Myers Squibb Research and Development, Hopewell, NJ, United States of America.
authors.forename: Jian
authors.initials: J
authors.lastname: Cao
authors.affiliation: Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut, United States of America, 06492.
authors.forename: Ryan
authors.initials: R
authors.lastname: Willard
authors.affiliation: Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut, United States of America, 06492.
authors.forename: Baiqing
authors.initials: B
authors.lastname: Lin
authors.affiliation: Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut, United States of America, 06492.
authors.forename: Betsy
authors.initials: B
authors.lastname: Eggers
authors.affiliation: Discovery Virology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut, United States of America, 06492.
authors.forename: Fiona
authors.initials: F
authors.lastname: McPhee
mesh_terms: D002478:Cells, Cultured; D015536:Down-Regulation; D016174:Hepacivirus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D022781:Hepatocytes / Q000821:virology*; D006801:Humans; D007370:Interferon Type I / Q000378:metabolism*; D012367:RNA, Viral / Q000032:analysis; D053633:Receptor, Interferon alpha-beta / Q000235:genetics; D015398:Signal Transduction; D014779:Virus Replication
chemical_list: C507964:IFNAR1 protein, human; D007370:Interferon Type I; D012367:RNA, Viral; D053633:Receptor, Interferon alpha-beta
references.citation: J Virol. 2000 Mar;74(5):2293-304
references.pmid: 10666260
references.citation: Gastroenterology. 2013 Feb;144(2):414-425.e7
references.pmid: 23089201
references.citation: Stem Cells. 2001;19(5):378-87
references.pmid: 11553846
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: EMBO J. 2003 Feb 3;22(3):537-47
references.pmid: 12554654
references.citation: J Mol Biol. 2004 Jul 30;341(1):303-18
references.pmid: 15312780
references.citation: J Clin Gastroenterol. 1998 Mar;26(2):135-40
references.pmid: 9563926
references.citation: Science. 1998 Oct 2;282(5386):103-7
references.pmid: 9756471
references.citation: Nat Methods. 2005 May;2(5):345-50
references.pmid: 15846361
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
references.pmid: 15939869
references.citation: World J Gastroenterol. 2005 Jul 7;11(25):3962-5
references.pmid: 15991303
references.citation: Science. 2005 Jul 22;309(5734):623-6
references.pmid: 15947137
references.citation: Gastroenterology. 2005 Aug;129(2):522-7
references.pmid: 16083709
references.citation: Nature. 2005 Aug 18;436(7053):946-52
references.pmid: 16107834
references.citation: J Mol Biol. 2005 Oct 21;353(2):271-81
references.pmid: 16171819
references.citation: Hepatology. 2006 May;43(5):954-60
references.pmid: 16628671
references.citation: Biochem J. 2006 Jul 1;397(1):31-8
references.pmid: 16551269
references.citation: Gut. 2006 Aug;55(8):1188-96
references.pmid: 16120756
references.citation: Hepatology. 2006 Oct;44(4):896-906
references.pmid: 17006906
references.citation: N Engl J Med. 2006 Dec 7;355(23):2444-51
references.pmid: 17151366
references.citation: Gastroenterology. 2006 Dec;131(6):1887-98
references.pmid: 17087946
references.citation: Nucleic Acids Res. 2007 Jan;35(Database issue):D61-5
references.pmid: 17130148
references.citation: Hepatology. 2014 Jun;59(6):2403-12
references.pmid: 24155107
references.citation: J Hepatol. 2014 Aug;61(2):219-27
references.pmid: 24727123
references.citation: J Hepatol. 2014 Dec;61(6):1238-46
references.pmid: 25064437
references.citation: Gut. 2008 Apr;57(4):516-24
references.pmid: 17895355
references.citation: N Engl J Med. 2011 Jun 23;364(25):2405-16
references.pmid: 21696307
references.citation: Clin Res Hepatol Gastroenterol. 2011 Jun;35 Suppl 1:S31-41
references.pmid: 21742299
references.citation: PLoS One. 2011;6(7):e22200
references.pmid: 21779393
references.citation: Hepatology. 2011 Dec;54(6):1913-23
references.pmid: 21800339
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2544-8
references.pmid: 22308485
references.citation: Gastroenterology. 2012 Apr;142(4):978-88
references.pmid: 22248663
references.citation: Nat Med. 2013 Jul;19(7):879-88
references.pmid: 23836238
references.citation: Am J Pathol. 2014 Jan;184(1):214-29
references.pmid: 24215913
references.citation: J Biol Chem. 2014 Feb 21;289(8):5310-9
references.pmid: 24385435
references.citation: PLoS One. 2014;9(4):e93434
references.pmid: 24691098
references.citation: J Viral Hepat. 2014 Jun;21(6):e1-9
references.pmid: 24827902
references.citation: Hepatology. 2014 Jun;59(6):2121-30
references.pmid: 24122862
references.citation: Proc Natl Acad Sci U S A. 2008 May 13;105(19):7034-9
references.pmid: 18467494
references.citation: Biofactors. 2009 Jan-Feb;35(1):82-7
references.pmid: 19319850
references.citation: Mol Cell Biol. 2009 Sep;29(17):4841-51
references.pmid: 19564419
references.citation: N Engl J Med. 2010 Apr 8;362(14):1292-303
references.pmid: 20375406
references.citation: Gastroenterology. 2011 Mar;140(3):1021-31
references.pmid: 21111740
references.citation: N Engl J Med. 2011 Mar 31;364(13):1195-206
references.pmid: 21449783
references.citation: N Engl J Med. 2011 Mar 31;364(13):1207-17
references.pmid: 21449784
references.citation: Nature. 2011 Apr 28;472(7344):481-5
references.pmid: 21478870
references.citation: PLoS Pathog. 2012;8(4):e1002617
references.pmid: 22496645
references.citation: Nat Rev Gastroenterol Hepatol. 2012 Jul;9(7):406-17
references.pmid: 22641049
references.citation: PLoS One. 2012;7(7):e41209
references.pmid: 22911761
references.citation: Eur J Immunol. 2012 Sep;42(9):2374-82
references.pmid: 22685015
references.citation: Antimicrob Agents Chemother. 2012 Oct;56(10):5387-96
references.pmid: 22869577
references.citation: J Virol. 2012 Oct;86(20):11043-56
references.pmid: 22855484
references.citation: Semin Immunopathol. 2013 Jan;35(1):53-72
references.pmid: 22868377
references.citation: Antimicrob Agents Chemother. 2013 Mar;57(3):1312-22
references.pmid: 23274666
references.citation: J Hepatol. 2013 Mar;58(3):564-74
references.pmid: 23063572
references.citation: PLoS Pathog. 2013;9(4):e1003316
references.pmid: 23637605
references.citation: N Engl J Med. 2013 May 16;368(20):1867-77
references.pmid: 23607593
references.citation: N Engl J Med. 2013 May 16;368(20):1878-87
references.pmid: 23607594
references.citation: J Infect Dis. 2000 Jul;182(1):28-35
references.pmid: 10882578